Results 231 to 240 of about 105,036 (275)

Enantioselective Growth of Chiral Serine‐Induced β‐Ag2Se Crystals from an Organoselenium Compound

Advanced Functional Materials, EarlyView.
Chiral amino acids direct the enantioselective crystallization of β‐Ag2Se nanocrystals from an organoselenium precursor. L‐ and D‐serine induce distinct morphologies and opposite homochiral adsorption preferences, transferring molecular handedness into the inorganic lattice.
Matan Oliel, Yarden B. Moshe, Gil Otis, Dana D. Medina, Yitzhak Mastai, Subhomoy Das   +5 more
wiley   +1 more source

Pharmaceutical access in Brazil: challenges and opportunities. [PDF]

Global Health
Ruas CM, Portela R, de Assis Acurcio F, Alvares-Teodoro J, Guerra Júnior AA, Kesselheim AS.   +5 more
europepmc   +1 more source

Introducing Pure Calcium Orthophosphate Gels and Aerogels

Advanced Functional Materials, EarlyView.
The synthesis of calcium phosphate‐based gels and aerogels is reported, which exhibit highly porous structures built up of networks of nanoparticles. In case of amorphous aerogels, this leads to yet unmatched specific BET surface areas, making these materials especially interesting for biomedical applications.
Oliver Jeske, Dominik Zanker, Nina Ehlert, Bing‐Qiang Lu, Denis Gebauer   +4 more
wiley   +1 more source

Impact of equivalent units of production on state-controlled unit cost calculation for fair pricing of pharmaceuticals: a scoping review. [PDF]

J Pharm Policy Pract
Udoh S, Wnuk-Pel T.
europepmc   +1 more source

Liquid Crystalline Inverted Lipid Phases and Reverse Micelles in Drug Delivery: From Molecular Design to Therapeutic Potential

Advanced Functional Materials, EarlyView.
Liquid crystalline inverted lipid phases and reverse micelles are self‐assembled lipid nanostructures that enhance the solubility, stability, and delivery of diverse therapeutics. This review integrates their physicochemical principles, formulation strategies, drug loading mechanisms, and biomedical applications, highlighting their growing ...
Numan Eczacioglu, Mulazim Hussain Asim, Soheil Haddadzadegan, Andreas Bernkop‐Schnürch   +3 more
wiley   +1 more source

Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine Neoplasms. [PDF]

JCO Precis Oncol
Thummalapalli R, Tendler S, Chou JF, Tarcan ZC, Porfido C, Willner J, Linkov I, Bhanot U, Cooper AJ, Xu J, Harding JJ, Rekhtman N, Tang LH, Rudin CM, Janjigian YY, Schöder H, Porier JT, Shia J, Basturk O, Reidy-Lagunes D, Capanu M, Lewis JS, Bodei L, Dunphy MP, Raj N.   +24 more
europepmc   +1 more source

Sandoz Inc. v. Amgen Inc.: Removing Barriers to Market Access for Biosimilar Manufacturers [PDF]

, 2019
Koya, Moyosore O.
core   +1 more source

Assessing concentration in the monoclonal antibody innovation market: A patent-based study. [PDF]

PLoS One
Motta-Santos AS, Ribeiro LC, Gow J, Alam K, de Souza Noronha KVM, Andrade MV.   +5 more
europepmc   +1 more source

Equitable access to costly new drugs.

BMJ
Woods B, Ten Ham R, Claxton K.
europepmc   +1 more source

Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal Adenocarcinoma. [PDF]

JCO Precis Oncol
Wenric S, Sangli C, Guittar J, Islam F, Zander A, Won Hyun S, Davison JM, Mayhew GM, Beebe K, Beauchamp K, Patel M, Brown K, Chen J, Nimeiri H, Milburn MV, Perou CM, Guinney J, Taxter TJ, Benson A.   +18 more
europepmc   +1 more source